(Q46161380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Subbiah Sridhar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Rama Walia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Anil Bhansali

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

454-459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22816533%20AND%20SRC:MED&resulttype=core&format=json

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Androgens, insulin resistance and vascular disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Low testosterone and anaemia in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Osteoporosis in men: a review of endogenous sex hormones and testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Assessment of sexual health in aging men in Europe: development and validation of the European Male Ageing Study sexual function questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

A critical evaluation of simple methods for the estimation of free testosterone in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Inflammation: the link between insulin resistance, obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Bone metabolism in type 2 diabetes and role of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04510.X